The Limited Times

Now you can see non-English news...

Worrying: Pfizer will halve the amount of vaccines distributed Israel today

2020-12-04T21:58:52.286Z


The pharmaceutical company encountered a logistical obstacle in the supply of raw materials • It is not clear whether the decision will affect the transfer of vaccines to Israel | United States


The pharmaceutical company encountered a logistical obstacle in the supply of raw materials, as a result of which the production process will be delayed • It is not clear whether the decision will affect the transfer of vaccines to Israel

  • Pfizer Logistics Center in the US // Photo: AFP

Pharmaceutical giant Pfizer announced tonight (Thursday) that it will halve the amount of vaccines for the corona virus that will be distributed to its customers in the coming weeks, due to a logistical problem that created the supply of one of the raw materials used by the company.

The announcement could be a blow to some countries expecting to receive the vaccine doses, but the company claims to meet the target of distributing one billion vaccine doses by 2021. "Increasing the supply chain of some raw materials turned out to be longer than planned The company's spokesman for the American Wall Street Journal.

The company hoped to transfer more than one hundred million vaccine doses to various sources during the last month of 2020, but now the company estimates that only fifty million doses will be distributed.

It is not clear at this stage how the cuts will affect the transfer of the vaccine to Israel.

Earlier it was reported that four million vaccine doses will arrive in Israel as early as next month.

In a meeting held yesterday (Wednesday) between the Director General of the Ministry of Health, Prof. Hezi Levy, and the directors of the HMOs, the senior official announced that the mass immunization process is expected to begin as early as the end of December.

Source: israelhayom

All news articles on 2020-12-04

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.